🧬 Omics-Insights: Your Weekly Genomics & Proteomics Digest 🧬
Welcome to our latest Omics newsletter, your portal for the freshest updates and innovations in genomics. This week's newsletter brings you the latest updates from the dynamic world of Omics. In this edition, we bring you the latest developments in the dynamic world of Omics, including key industry news, strategic collaborations, skill development essentials for finding a new job, & essential career tips for omics professionals.
This week's latest news in the field of Life Science:
Illumina Expands Partnership with Pillar Biosciences for Cancer Panels 🔬 Illumina and Pillar Biosciences are expanding their partnership to offer more of Pillar’s OncoReveal NGS cancer panels, including the Myeloid, Multi-Cancer, and BRCA1/BRCA2 panels, on Illumina's MiSeq i100 sequencer. This move enhances Illumina's product portfolio with oncology assays for solid tumors and liquid biopsies, reinforcing their commitment to advancing cancer diagnostics. While financial details were not disclosed, this collaboration builds on their global distribution agreement from 2017.
Nuclera Raises $75M to Revolutionize Protein Expression 🚀 Nuclera has secured $75 million in a Series C round, led by Elevage Medical Technologies, to accelerate the commercialization of its eProtein Discovery platform. This benchtop system enables rapid, cell-free protein production in less than 48 hours, streamlining drug discovery. Installed at top academic institutions and biopharma firms, the platform addresses key protein accessibility challenges. CEO Michael Chen emphasized the significant market demand as AI and structural biology fuel life sciences innovations.
Shift Bioscience Secures $16M to Boost AI-Driven Cell Rejuvenation Tech 🧬 Shift Bioscience has raised $16 million in seed funding, led by BGF, to advance its AI-powered cell simulation platform aimed at treating age-related diseases. The platform identifies gene targets to rejuvenate cells by predicting which gene sets are most effective. CEO Daniel Ives highlighted that this funding will accelerate their efforts to bring cell rejuvenation therapies closer to clinical trials, addressing the limitations of current cellular reprogramming approaches.
Proteomics Unveils New Hope for Treating Severe Skin Disease 🔬 Using advanced spatial proteomics, researchers have linked the deadly skin condition toxic epidermal necrolysis (TEN) to heightened JAK/STAT pathway activity, suggesting JAK inhibitors as a potential treatment. Published in Nature, the study reveals key molecular insights into TEN’s pathology and shows promising results from early JAK inhibitor treatments in patients. This breakthrough could pave the way for targeted therapies in dermatology and other complex skin conditions.
Bruker Wins Patent Case Against 10x Genomics in European Court ⚖️ Bruker's NanoString division scored a victory in the European Unified Patent Court, which invalidated 10x Genomics’ European Patent No. 2794928B1. This marks the third court decision invalidating the patent in under a year, following a similar ruling by the German Federal Patent Court. The case is still subject to appeal, with another 10x patent dispute ongoing. Bruker acquired NanoString earlier this year after the company filed for bankruptcy.
Current Live Roles at Kinetica:
Senior Director of Manufacturing - Proteomics - Maryland
Recommended by LinkedIn
Senior Scientist - Flow Cytometry - Maryland
Senior Account Manager - NGS Reagents - LA
Field Service Engineer - Proteomic Equipment - Belgium
Director of Product Management. - Imaging Equipment - EMEA
Senior Account Manager - Proteomic Equipment - Belgium
Business Development Manager - NGS - DACH
Business Development Manager - Proteomics - Nordics
Field Application Scientist - Proteomics - Paris
Field Service Engineer - Spatial Biology - EMEA
Sales Manager - Genomics Reagents - UK
Job Hunting Tips from an Omics Specialist Recruiter: How to Nail Your 1st Stage Interview 🎯
With the right preparation, you’ll demonstrate both your technical expertise and your enthusiasm for the opportunity. Good luck! 🍀
Wrapping Up Another Omics-Insights:
Thank you for embarking on a journey into the dynamic world of Omics with Kinetica! Explore the latest genomics job opportunities, stay informed with industry news, and indulge in insightful blogs at www.kinetica.co.uk. Your curiosity drives my commitment to relevant content, and I'm here to provide insights that fuel your scientific endeavors. Feel free to reach out with any questions or feedback. Wishing you ongoing inspiration and discovery in your scientific pursuits. Until next week, may your experiments yield groundbreaking results, and may your Omics journey remain as fascinating as the science itself!